Sign Up Today and Learn More About dbt Labs Stock
Invest in or calculate the value of your shares in dbt Labs or other pre-IPO companies through EquityZen's platform.
About dbt Labs Stock
Founded
2016
Headquarters
Philadelphia, PA, US
Industries
Software, Artificial Intelligence, Data and Analytics
dbt Labs is a developer of an open-source analytics engineering tool driven by a mission to help analysts create and disseminate organization knowledge. Its platform enables data analysts to easily create and disseminate organizational knowledge through data modeling, thereby allowing clients with SQL knowledge to build data transformation workflows. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
dbt Labs Press Mentions
Stay in the know about the latest news on dbt Labs
Swing States Are Also In The Middle For Startup Funding
news • Oct 30, 2024
dbt Labs' Coalesce 2024 Unifies Data Practitioners and Data Leaders With One dbt
prnewswire • Oct 21, 2024
dbt Labs Names Seasoned Channel Leader Shawn Toldo Vice President, Worldwide Partner Ecosystem
prnewswire • Oct 09, 2024
dbt Labs Unveils AI Innovations and New Features to Improve Collaboration and Multi-platform Analytics
prnewswire • Oct 08, 2024
Indicium Earns Emerging Partner of the Year Award, Americas, from dbt Labs
globenewswire • Oct 08, 2024
Investors in dbt Labs
Discover investors in dbt Labs stock and explore their portfolio companies
dbt Labs Management
Leadership team at dbt Labs
Chief Executive Officer
Tristan Handy
Chief Financial Officer
Daniel Le
Join now and verify your accreditation status to gain access to:
- dbt Labs current valuation
- dbt Labs stock price
- Available deals in dbt Labs and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading dbt Labs Stock
How to invest in dbt Labs stock?
Accredited investors can buy pre-IPO stock in companies like dbt Labs through EquityZen funds. These investments are made available by existing dbt Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell dbt Labs stock?
Shareholders can sell their dbt Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
